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Long life is a topic of great interest in medicine and among the general public. 
The “successful aging” which is a high priority for individuals and societies, 
is aging without any disabilities and severe diseases. In several countries, the 
increase in life expectancy has led the very old to become the fastest growing seg-
ment of the population. Centenarians are subjects living 100 years or older. The 
majority of centenarians are females (female to male ratio around 3.6/1). A very 
small fraction of centenarians (up to 0.5%) will live 110 years or older (supercen-
tenarians). Most centenarians have managed to avoid, postpone, or overcome the 
important age-related and life-threatening diseases and disabilities (e.g., ischemic 
heart disease, stroke, chronic obstructive pulmonary disease, cancer, respiratory 
infection, type 2 diabetes, osteoporosis, and dementia). Some forecasts suggest 
that most babies born in developed countries since 2000 will become centenari-
ans. In 2020, the number of centenarians in the world was approximately 573,000, 
mainly from the United States of America (USA). This number could reach 
approximately 3,676,000 by 2050. In the absence of the genetic predisposition 
to become centenarian, there are several ways to extend longevity (e.g., lifestyle, 
reduction of several life-threatening diseases and disabilities, hormonal replace-
ment or blockade, antioxidants, maintenance of a proper autophagic activity, 
stem cell therapy, and gene therapy). The continuous increase of the number of 
centenarians has worldwide practical implications including profound impact on 
intergenerational interactions and significant financial challenges for any society, 
especially in relation to medical expenses.
Keywords: centenarians, supercentenarians, longevity, genetics, emerging 
population
1. Introduction
Long life is a topic of great interest in medicine and among the general public. In 
several countries, the increase in life expectancy has led the very old to become the 
fastest growing segment of the population [1–4]. Centenarians are subjects living 
100 years or older. Most centenarians have managed to avoid, postpone, or over-
come the important age-related and life-threatening diseases [3, 5, 6].
The continuous increase of the number of centenarians has worldwide practi-
cal implications including profound impact on intergenerational interactions and 




2. Aging and lifespan
Aging is a natural universal phenomenon affecting all living organisms (e.g., 
plants, animals, and humans). It is a progressive deterioration of the cell and 
organ functioning due to damage accumulation over time. The exact underlying 
mechanisms of aging at the cellular level are not fully understood. The most popular 
theory is the free radical theory [7].
Lifespan is a biological characteristic of every species. However, it can be 
modified by mutations or by a variety of interventions (e.g., lifestyle, pharmaco-
logical, stem cell, and genetic interventions) [8–24].
Lifespan of living organisms ranges from few hours (animals) to few thousand 
years (plants). Phenotypic plasticity can affect the long lifespan of both plants and 
animals [25].
2.1 Plants
The lifespan in plants ranges from few weeks to few thousand years. Bristlecone 
pine (Pinus longaeva), a tree found in the higher mountains of California (USA), is 
among the plants with the longest lifespan (around 5,000 years) (Figure 1).
2.2 Animals
The lifespan in animals is between few hours to few hundred years. The shortest 
lifespan is seen with mayfly (up to 24 hours). The longest lifespan is observed with clam 
(more than 400 years). Ming the clam was the oldest clams ever discovered (507 years 
old). Ming was accidentally killed in 2006 during a fact-finding mission (Figure 2).
Figure 1. 
Bristlecone pine (Pinus longaeva) can live around 5,000 years (Picture downloaded from the internet “Google 
Images”).
Figure 2. 
Ming the clam lived 507 years (Picture downloaded from the internet “Google Images”).
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2.3 Humans
The theoretical lifespan in humans is around 120 years. However, very few 
individuals reach this theoretical age since several events can impact longevity 
(e.g., diseases, suicide, accident, and war).
Human aging results from accumulation of genetic, molecular, and cellular 
damages. It is a multifactorial process. There are several theories explaining the 
aging phenomenon. The most wildly accepted theory of aging is the free radical 
theory [7]. According to this theory, continuous, unrepaired oxidative damage of 
macromolecules constitutes the molecular basis of aging.
Aging and lifespan are influenced by multiple factors including genetic, 
epigenetic, lifestyle, environmental, metabolic, and endocrine factors  
[3, 8–14, 21, 26–41].
Extending longevity while keeping health and vitality has been a dream for 
mankind since ancient times. The “successful aging” which is a high priority for 
individuals and societies, is aging without any disabilities and severe diseases [42, 43]. 
The fountain of youth is a mythical spring capable of restoring the youth of anyone 
who drinks or bathes in its water (Figure 3).
2.3.1 Physiological changes associated with aging
With aging, there is a gradual, time-dependent, and heterogeneous decline 
of physiological functions (Figure 4). The human body goes through multiple 
physiological changes including an overall decrease in the size of organs (e.g., brain 
shrinkage), endothelial pro-atherosclerotic changes, ovarian atrophy, osteopenia 
(predominantly in women), sarcopenia (mainly in the lower body), adipose 
tissue enlargement (mostly visceral fat), and skin atrophy (especially in women) 
(non-exhaustive list) [9, 10, 32, 41]. Some changes are very subtle (within normal 
ranges) with no or unknown clinical consequences. Lifestyle conditions (e.g., diet, 
exercise, and medications) and environmental factors (e.g., noise, temperature, 
and air quality) can delay or potentiate these changes.
Autophagy (“self-eating”) is a major protein turnover pathway where cellular 
components are delivered into the lysosomes for degradation and recycling. It 
maintains cellular homeostasis under stress conditions. The autophagic activity 
decreases in aging individuals [21].
Figure 3. 




Mitochondria are major contributors to the maintenance of energy homeostasis. 
They are important sources of reactive oxygen species (ROS) generation. ROS can 
cause oxidation of macromolecules including DNA. Aging subjects have progressive 
mitochondrial decline [10, 11, 39, 44].
Aging is associated with a mild inflammatory state that is sometimes referred 
to as “inflammaging”. This inflammatory state is characterized by increased blood 
levels of several adipokines (e.g., interleukin 6 and tumor necrosis factor alpha). 
Environmental factors can further modify the inflammatory state of aging [32].
Multiple endocrine changes occur with aging, affecting the body functions  
[9, 10, 12, 31, 35–37, 39–41, 45–49]. The hypothalamus, an endocrine structure 
located in the brain that is a master regulator of multiple hormonal secretion, plays 
a central role in aging. With aging, the sensitivity of the hypothalamus to different 
feedback signals decreases [36]. Growth hormone (GH) and insulin-like growth 
factor-1 (IGF-1) levels decline during aging [37]. According to most studies, free 
triiodothyronine (T3) levels decrease while reverse T3 (rT3) and thyroid-stimu-
lating hormone (TSH) levels increase [45–47] with aging. Significant hormonal 
change occurs in women at menopause with important reduction in estrogen (E) 
levels [48]. In men, testosterone (T) levels decrease gradually with age [40]. There 
is an important decrease in dehydroepiandrosterone (DHEA) levels in aging indi-
viduals [49]. Adipose tissue, which is the largest endocrine gland, secretes several 
adipokines. With aging, there is an increase in the levels of most adipokines (e.g., 
leptin, resistin, interleukin 6, tumor necrosis factor alpha, and adiponectin) [41].
The relevant metabolic/hormonal changes during normal aging are reported in 
Table 1.
Figure 4. 
Aging is associated with a gradual decline of different functions and performances (Picture downloaded from 
the internet “Google Images”).
Parameter Change
Mitochondrial activity Decrease (gradual)
Autophagic activity Decrease (gradual)





TSH Increase (subtle, at old age)
E (females) Decrease (abrupt, at menopause)
T (males) Decrease (gradual)
DHEA Decrease (gradual)
Adipokines Increase (gradual)
Insulin resistance Increase (gradual)
Table 1. 
Relevant metabolic/hormonal changes during normal aging.
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2.3.2 Genetic and epigenetic factors affecting aging and lifespan
Genes play an important role in the regulation of aging and lifespan [3, 8, 10, 
27–29, 31, 50]. Extensive number of genes (between 300 to over 700 genes) have 
been listed [28, 29]. Genes include APOE1, ATM, BCL, CETP, FOXO3A, HSPA, and 
TERC (non-exhaustive list). Genetic factors that are associated with longevity are 
heritable [27]. Several endocrine and metabolic pathways are linked genetically 
with aging and contribute to different phenotypes [31]. Multiple gene mutations 
leading to delayed aging and increased lifespan have been discovered over the last 
three decades. Many of the affected genes are components of endocrine-signaling 
pathways (e.g., GH and IGF-1 pathways).
A dramatic example of genetic impact on aging and lifespan is observed with 
Hutchinson-Gilford progeria syndrome, a rare sporadic, autosomal  
dominant syndrome that causes premature aging. In most cases, the disorder  
is due to a mutation characterized by a change from glycine GGC to glycine GGT 
in codon 608 of exon 11 of the lamin A (LMNA) gene causing the production of 
an abnormal lamin A (progerin). Progerin accumulates in cells’ nuclei and exerts 
multiple toxic effects [50]. The affected individuals generally die from myocardial 
infarction or stroke around a mean age of 15 years (Figure 5).
Epigenetic processes also influence aging and lifespan [8, 9, 11, 26, 30].
2.3.3 Lifestyle and environmental factors affecting aging and lifespan
Lifestyle (e.g., diet, sleep, smoking, exercise, stress, and medications) and 
the environment (e.g., household, social condition, noise, temperature, and  
air quality) play an important role in the aging process and lifespan (Figure 6) 
[8, 9, 26, 51].
Caloric restriction, physical fitness, and good air quality can delay aging and 
increase lifespan. Conversely, excessive food consumption, sedentary lifestyle, and 
air pollution will have a negative impact on aging and lifespan.
Figure 5. 




2.3.4 Metabolic factors affecting aging and lifespan
Metabolic factors play an important role in the aging process and lifespan 
(Figure 7) [10, 11, 21, 33, 34, 39, 41, 44].
The decrease in autophagic activity observed with aging contributes to accumu-
lation of damaged macromolecules and organelles. It can aggravate age-associated 
diseases and, therefore, shorten lifespan [21].
Mitochondria play a key role in several theories of aging. The reduction in 
mitochondrial activity with aging can impact lifespan [10, 11, 39, 44].
The inflammatory state associated with aging is responsible for insulin resis-
tance. Insulin resistance is a risk factor for the development of several chronic 
disorders (e.g., obesity, type 2 diabetes, and ischemic heart disease) that are 
influencing aging and lifespan [10, 14, 42].
The amount of body fat influences health and lifespan. Both insufficient or excess 
body fat as observed in subjects with underweight or overweight/obesity have been 
reported to be associated with increased mortality and reduced lifespan [33, 34, 41].
2.3.5 Endocrine factors affecting aging and lifespan
Hormones influence the aging process and lifespan (Figure 8) [9, 10, 12, 13, 31, 
35–41, 45–49, 52–54]. Several endocrine-signaling changes occur during normal 
Figure 6. 
Lifestyle and environmental factors can affect aging and lifespan (Picture downloaded from the internet 
“Google Images”).
Figure 7. 
Metabolic factors impact aging and lifespan (Picture downloaded from the internet “Google Images”).
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aging. Some hormonal changes may be beneficial while others can be harmful. The 
role of GH in aging and lifespan has been reported in several studies [37, 38, 52]. 
Reduced GH may lead to delay aging and increased lifespan while excess GH can have 
the opposite effects. GH secretion rate in offspring of long-lived families is lower than 
controls. Thyroid hormones play an important role in aging and  lifespan. There is a 
negative correlation between thyroid hormone levels and  lifespan [39]. The timing of 
menopause, a physiological condition occurring in women around the age of 50 years 
and associated with important decrease in E levels, may affect lifespan [48]. Indeed, E 
replacement therapy can reduce mortality (increase of lifespan) in post-menopausal 
women younger than 60 years [13]. In men, low T levels are associated with increased 
mortality [40]. Treatment with DHEA decreases insulin resistance and inflammatory 
adipokines and may positively impact lifespan [53]. The elevated levels of pro-inflam-
matory adipokines (e.g., interleukin 6 and tumor necrosis factor alpha) can negatively 
impact aging and lifespan. Elevated levels of adiponectin (anti-inflammatory adipo-
kine) may be beneficial and associated with increased lifespan [41, 54].
2.3.6 Disease occurrence with aging
The “successful aging” is aging without any disabilities and severe diseases 
(extension of healthspan) [42, 43]. It is more important to promote healthier aging 
than better treat age-related diseases.
Figure 8. 
Endocrine factors influence aging and lifespan (Picture downloaded from the internet “Google Images”).
Figure 9. 
Multiple organs can be affected in aging subjects (Picture downloaded from the internet “Google Images”).
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Several geriatric syndromes (e.g., frailty) and diseases (e.g., cardiovascular dis-
ease) occur with aging and affect quality of life and longevity [19, 42]. The incidence 
of adult diseases increases with age. In subjects older than 60 years, the most common 
age-related and life-threatening diseases and disabilities are ischemic heart disease, 
stroke, chronic obstructive pulmonary disease, cancer, respiratory infection, type 
2 diabetes, osteoporosis, and dementia (non-exhaustive list) [14, 42]. The majority 
of older people may have more than one disorder. The incidence of multimorbidity 
(e.g., three or more diseases) increases exponentially with aging (Figure 9) [15]. For 
several of these conditions, the burden is greater in low-income and middle-income 
countries [42]. Some diseases (e.g., thyroid diseases) may have subtle symptoms that 
can be attributed to normal aging [55].
2.3.7 Life expectancy
At the beginning of the 20th century, life expectancy in most developed coun-
tries was between 45 and 50 years. Over the last several decades, there has been a 
gradual increase in life expectancy in most countries [27, 56]. The study of mortality 
and life expectancy in 195 countries and territories showed that globally, between 
1950 and 2017, life expectancy increased from 48.1 years to 70.5 years for men and 
from 52.9 years to 75.6 years for women [56].
In less developed countries, the increase in life expectancy is mainly the result 
of reduced mortality at younger ages. In high-income countries, the increase in life 
expectancy is mainly due to rising life expectancy in subjects who are 60 years or older.
The increase in life expectancy together with the decrease in fertility rates are 
leading to the rapid aging of populations around the world. This has important 
demographic and socio-economic consequences worldwide.
3. Centenarians
Centenarians are subjects living 100 years or older. They represent a model of 
successful aging [3, 5, 6]. Semi-supercentenarians are those who reach an age of 
105–109 years. A very small fraction of centenarians (up to 0.5%) will live 110 years 
or older (supercentenarians) [5, 30].
3.1 Prevalence
The total world population is currently around 7.8 billion and is projected to 
reach 9.9 billion by 2050. In several countries, the increase in life expectancy has 
led the very old to become the fastest growing segment of the population [1–4]. 
Some forecasts suggest that most babies born in developed countries since 2000 
will become centenarians.
Estimates of the centenarian population can be difficult since some centenar-
ians do not have birth records to confirm their age. According to United Nations 
estimates, in 2020, the number of centenarians in the world was approximately 
573,000. This number was approximately 34,000 in 1950 and could reach 
approximately 3,676,000 by 2050.
3.1.1 Prevalence by gender
The majority of centenarians are females. The female to male ratio is currently 
around 3.6/1 and is expected to be approximately 2.9/1 by 2050 (Figure 10).
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3.1.2 Prevalence by country
Currently, USA has the highest number of centenarians, followed by Japan, 
China, India, and Italy. Japan and Italy have the highest proportion of centenarians 
to the total population. By 2050, China is expected to have the largest centenarian 
population, followed by Japan, USA, Italy, and India (Table 2).
The oldest supercentenarian with well-documented age was Jeanne Louise 
Calment (1875–1997) from Arles, France who lived 122 years (Figure 11). She married 
at the age of 21 years, had one pregnancy (gave birth to a girl), and never worked. 
With the exception of migraines and bilateral cataracts, she was quite healthy and 
remained mentally sharp until the end of her life. She did daily gymnastics and was 
socially active. She never took any medication apart from aspirin for migraines. She 
enjoyed chocolate, drank a small daily amount of wine, smoke a cigarette after each 
meal, and took a nap in the afternoon. She also had a good sense of humor. To the 
question “Why do you live so long?”, she replied “Because God has forgotten me”.
Figure 10. 
Centenarians are mainly females but the female to male ratio is gradually decreasing (Picture downloaded 
from the internet “Google Images”).
Country Last Reported Number (Year) Expected Number by 2050
World 573,000 (2020) 3,676,000
USA 97,000 (2020) 378,000
Japan 80,000 (2020) 441,000
China 48,000 (2015) 620,000
India 27,000 (2015) 207,000
Italy 25,000 (2015) 216,000
Table 2. 
Number of centenarians worldwide and in top five countries (United Nations and national sources).
Figure 11. 
Jeanne Louise Calment from Arles, France (1875–1997), the oldest confirmed supercentenarian who lived 




Maintenance of a proper autophagic activity may contribute to extended 
longevity. Healthy centenarians have autophagy augmentation as reflected by 
increased levels of beclin-1, a key regulator of autophagy [57].
Lower thyroid hormone levels and higher TSH levels have been reported to be 
associated with increased longevity [31, 39, 45–47]. Centenarians have higher TSH 
levels compared to controls, partly due to a genetic background [31].
Adiponectin levels are elevated in centenarians and associated with a favorable 
metabolic phenotype. They may contribute to extended longevity [41, 54].
Frailty plays an important role in health outcomes and mortality. A study of 
Chinese centenarians demonstrated that centenarians are frailer than younger 
elders. Management of frailty can help achieving healthy longevity [58]. A study of 
centenarians living in New York City (USA) showed that despite reduced levels of 
physical functioning and social resources, centenarians were in good mental health 
suggesting high resilience and ability to adapt to age-associated challenges [59].
3.3 Genetic/epigenetic profile
There is a strong genetic influence in subjects with extreme longevity  
(Figure 12) [3, 8, 10, 27, 31]. Genetic component may include several genetic 
modifiers each with modest effects, but as a group, they can have a strong impact 
[27]. Several genotypes known to influence longevity are enriched in centenar-
ians (e.g., CETP-VV and FOXO3A-T) [10]. Homozygosity in the 405VV variant 
of CETP (cholesterol ester transfer protein) gene is associated with lower con-
centrations of CETP, higher concentrations of high-density lipoprotein (HDL) 
cholesterol, and larger HDL particle size, all associated with protection against 
ischemic heart disease and Alzheimer disease. FOXO3A (forkhead box O3A) gene 
is a member of a family of transcription factors mediating insulin action and 
stress resistance. Several gene mutations responsible of extended longevity are 
components of endocrine-signaling pathways. For example, centenarians have a 
variety of genetic alterations in the GH/IGF-1 pathway causing reduced function 
of GH/IGF-1 pathway that is associated with protection from aging.
Epigenetic processes might also play a role in extreme longevity [8, 9, 11, 26, 30].
3.4 Lifestyle and environmental characteristics
Lifestyle is an important signature of healthy aging and extreme longevity [26]. 
There are significant lifestyle (e.g., diet) and cultural (e.g., social life) differences 
between the native of the top five countries (e.g., USA, Japan, China, India, and 
Italy) that have the highest numbers of centenarians. However, centenarians share 
Figure 12. 
Several longevity genes are enriched in centenarians (Picture downloaded from the internet “Google Images”).
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similarities for several lifestyle characteristics (Figure 13). The global calorie ingestion 
is reduced in centenarians in comparison to younger elders. Most centenarians have a 
plant-based diet, rich in vegetables, fruits, and oils, and usually a restricted intake of 
dairy products, red meat, and poultry [60]. A study of lifestyle of centenarians living 
in Zhejiang Province (China) showed significantly higher consumption of fruits, 
coarse cereals, and pasta, and lower percentage of smoking and engagement in daily 
recreational activities (watching television, listening to radio) compared to non-
centenarians [61].
Additional important lifestyle and environmental characteristics of centenarians 
are the presence of physical and mental activities (with daily objectives), psycho-
logical resilience, optimism, flexibility, and life in small towns with little pollution 
and significant social relationships. A study of health and functional status of 
Japanese centenarians suggested that maintenance of physical independence is a key 
factor of survival into extreme old age [62].
3.5 Disease occurrence and mortality
Centenarians have variable clinical conditions. Some may have multimorbidity 
while others have no significant diseases. However, some of the “healthy” centenar-
ians have signs of advanced aging (e.g., visual disorder, hearing loss, and limited 
locomotor capacity). Centenarian men tend to have better cognitive and physical 
functional status than centenarian women [3].
Most centenarians have managed to avoid (“escapers”), postpone, or over-
come (“survivors”) the important age-related and life-threatening diseases and 
disabilities (e.g., ischemic heart disease, stroke, chronic obstructive pulmonary 
disease, cancer, respiratory infection, type 2 diabetes, osteoporosis, and demen-
tia) [3, 5, 6]. Supercentenarians can compress morbidity and disability to the 
very ends of their lives.
A study assessing the place and cause of death of centenarians in England showed 
that centenarians more likely die of old age/frailty and respiratory infection and 
less likely of ischemic heart disease and cancer compared to younger elders [4]. 
Centenarians are relatively protected from cancers (lower incidence, lower metastatic 
rate, lower mortality). It has been hypothesized that the tumor suppressor gene p53 is 
a key element in protecting centenarians from cancers [6]. In Spanish centenarians, 
the likelihood of having the wild-type genotype of GSTT1, which is associated with 
lower cancer risk, was found to be higher than control, young subjects [63]. The top 
cancers in centenarians are breast, colorectal, prostate, and lung cancers [64].
The main causes of mortality in centenarians compared to younger elders are 
reported in Table 3.
Figure 13. 




4. Interventions to extend longevity
In the absence of the genetic predisposition to become centenarian, there are 
several potential ways to extend longevity and eventually surpass 100 years. The 
potential tools that can be proposed to extend longevity include lifestyle, reduc-
tion of several life-threatening diseases and disabilities, hormonal replacement or 
blockade, antioxidants, autophagy inducers, senolytic drugs, stem cell therapy, and 
gene therapy [8–24, 26, 33–35, 39, 41, 42, 51, 53, 65, 66].
4.1 Lifestyle
Diet rich in vegetables, fruits, fibers, and poor in saturated fat and red 
meat, even if associated with sarcopenia, may extend longevity [26, 65]. Anti-
inflammatory diets like Mediterranean diet are associated with reduced mortality 
from cardiovascular disease. Drinks containing sugar and alcohol consumption 
should be limited, and smoking avoided.
Based on animal data, it has been proposed that even in normal weight individu-
als, caloric restriction (cutting approximately 500 calories/day) without causing 
malnutrition and subsequent sarcopenia and osteopenia may improve health and 
extend longevity [8–11, 21, 26, 33, 35, 39, 66]. However, long-term prospective 
studies in humans are needed to confirm the benefits of this approach. Hypocaloric 
diet should be implemented in case of overweight or obesity.
Regular exercise can add few more years to life expectancy. Physical fitness is an 
important predictor of mortality and being able to live an independent life at old 
age. Potentiation of physical fitness is a valuable anti-aging therapy [11, 51].
In addition, living in a clean and stress-free environment, being mentally active 
with positive attitude, having daily objectives, and involved in social interactions 
further contribute to extended longevity.
4.2 Reduction of life-threatening diseases and disabilities
Overweight and obesity should be prevented or managed with appropriate tools 
(e.g., diet, exercise, drugs, medical devices, and surgery) to decrease comorbidities 
and mortality [33, 34, 41].
Reduction of other life-threatening diseases and disabilities that can affect longev-
ity (e.g., ischemic heart disease, stroke, chronic obstructive pulmonary disease, can-
cer, respiratory infection, type 2 diabetes, osteoporosis, and dementia) with lifestyle, 
drugs, and surgery can improve the quality of life and extend longevity [14, 15, 42].
Condition Mortality Rate
Younger Elders Centenarians
Old age/frailty 1% 28%
Respiratory infection 6% 18%
Ischemic heart disease 19% 9%
Cancer 25% 4%
Table 3. 
Main causes of mortality in centenarians compared to younger elders.
13
The Centenarians: An Emerging Population
DOI: http://dx.doi.org/10.5772/intechopen.96327
4.3 Hormonal replacement or blockade
Considering that some hormonal changes during aging are beneficial while 
others are harmful, it is tempting to use hormonal replacement or blockade to 
extend longevity [12, 13, 53].
GH represents an interesting and intriguing example in this regard. Although 
GH promotes health and vitality in young subjects and it is well established that 
its levels decrease with aging, several studies suggest that reduced GH can be 
more beneficial for overall health and longevity than excess GH [37, 38, 52]. This 
discourages the use of GH as an anti-aging treatment. However, additional clini-
cal studies are needed for a definitive conclusion on the role of GH/IGF-1 axis in 
aging [10].
E replacement therapy in post-menopausal women younger than 60 years has 
been reported to reduce mortality (extension of longevity) [13].
Treatment with DHEA has beneficial effects on insulin sensitivity (increase) 
and inflammatory adipokines (decrease) [53]. This can potentially reduce morbid-
ity and mortality.
4.4 Antioxidants
Free radical theory is an important theory of aging [7]. Oxidative stress signifi-
cantly influence the aging process and longevity. The use of antioxidants to combat 
aging has received considerable interest [16]. Several antioxidants (e.g., resveratrol 
and curcumin) are currently under investigation.
4.5 Autophagy inducers
Defects in autophagy have been linked to several diseases that can impact aging 
and lifespan. Maintenance of a proper autophagic activity with autophagy inducers 
has the potential to extent longevity [16, 20, 21]. Autophagy inducers include non-
pharmacologic tools (e.g., caloric restriction and exercise) and several nutritional 
supplements and approved drugs (e.g., vitamin D, resveratrol, metformin, and 
rapamycin) (non-exhaustive list). Novel and more specific autophagy-inducing 
drugs are under investigation.
4.6 Senolytic drugs
Senescence is a common feature occurring in several tissues and organs dur-
ing the aging process. Senotherapy represents a promising new therapeutic area  
[16, 19, 22, 23]. Senolytics are a class of drugs (e.g., dasatinib, quercetin, fisetin, 
and navitoclax) that selectively clear senescent cells. Several clinical studies 
are currently planned or ongoing. Results from early pilot studies suggest that 
senolytic drugs can decrease senescent cells, reduce inflammation, and alleviate 
frailty.
4.7 Stem cell therapy
Stem cell therapy represents a new emerging era in medicine (Figure 14) 
[16–18]. It has the potential to delay the aging process and, therefore, extend 





Genes are promising research targets to delay the aging process and extend lon-
gevity (Figure 15) [24]. Gene therapy allows the modulation of the genome architec-
ture using both direct (by gene editing) and indirect (by viral or non-viral vectors) 
approaches. However, these genetic interventions may be difficult to implement in 
humans without knowing all the potential health consequences during an entire life.
5. Consequences of extended longevity
Over the past three decades, the number of very old individuals, especially 
centenarians, has increased significantly. This has created (and will continue to 
create) challenges at the individual, family, and societal levels.
5.1 Individual aspects
With the availability of many extra years to live and if health permits, subjects 
may want to delay retirement age, continue education, undertake a new career, or 
pursue a passion (Figure 16).
Figure 14. 
Stem cell therapy has the potential to delay the aging process and extend longevity (Picture downloaded from 
the internet “Google Images”).
Figure 15. 
Genes can be targeted to delay the aging process and extend longevity (Picture downloaded from the internet 
“Google Images”).
Figure 16. 
Healthy elderly can benefit from additional education and job opportunities (Picture downloaded from the 
internet “Google Images”).
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5.2 Family aspects
Some centenarians have extended family over multiple generations. These 
individuals can enjoy interactions with their children, grandchildren, and great-
grandchildren at different stages of their life (Figure 17).
5.3 Societal aspects
There is an urgent need to assess the key characteristics of very old individuals, 
especially centenarians, across countries to better serve these populations and ensure 
a high quality of life in their remaining years [1, 2]. There is a requirement for nursing 
care at home or hospital. Increasing care home bed capacity could reduce dependence 
on hospital care at the end of life [4, 59].
The payment of pension and social security benefits to a growing number of 
very old subjects for several decades is a heavy financial challenge for any society. 
With extended longevity, there is an increasing number of subjects treated for at 
least three different diseases with at least three different treatments [15]. This will 
have a significant financial impact for the society (Figure 18). However, this situ-
ation may not be applicable to all centenarians since some have managed to avoid, 
postpone, or overcome several important age-related diseases and disabilities.
6. Conclusions
Long life is a topic of great interest in medicine and among the general public. 
The increase in life expectancy has led the very old to become the fastest growing 
segment of the population in several countries.
Figure 17. 
Centenarians can enjoy multigenerational family interactions (Picture downloaded from the internet “Google 
Images”).
Figure 18. 
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Centenarians are subjects living 100 years or older. The majority of centenarians 
are females and a very small fraction of centenarians are supercentenarians.
Most centenarians have managed to avoid, postpone, or overcome the impor-
tant age-related and life-threatening diseases (e.g., ischemic heart disease, stroke, 
chronic obstructive pulmonary disease, cancer, respiratory infection, type 2 
diabetes, osteoporosis, and dementia).
The continuous increase of the number of centenarians has worldwide practi-
cal implications including profound impact on intergenerational interactions and 
significant financial challenges for any society, especially in relation to medical 
expenses.
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